share_log

Outlook on the Transfection Technologies Global Market to 2026 - by Product Type, Application, Transfection Method, Technology, End-user and Region

Outlook on the Transfection Technologies Global Market to 2026 - by Product Type, Application, Transfection Method, Technology, End-user and Region

2026年转染技术全球市场展望--按产品类型、应用、转染方法、技术、最终用户和地区划分
PR Newswire ·  2021/09/03 18:46

DUBLIN, Sept. 3, 2021 /PRNewswire/ -- The "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

都柏林9月2021年3月/美通社/--《转基因技术市场：2021-2026年全球产业趋势、份额、规模、增长、机遇与预测》报告新增Research andMarkets.com的献祭。

The global transfection technologies market is expected to reach a value of US$ 1.5 Billion by 2026, exhibiting a CAGR of 8.44% during 2021-2026. Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

预计到2026年，全球转基因技术市场的价值将达到15亿美元，2021-2026年期间的复合年增长率为8.44%。转染技术是指人工将脱氧核糖核酸(DNA)、核糖核酸(RNA)和寡核苷酸等核酸导入细胞的过程。它是通过各种物理、化学和生物方法引入的，这些方法可以帮助改变细胞的某些属性。它涉及多种方法，包括共转染、电穿孔、阳离子脂质体转染和体内转染。这一过程通常用于各种基因组研究，包括基因表达、筛选、RNA干扰和活体研究，以及病毒和蛋白质的生物生产。癌症和各种慢性生活方式疾病的日益流行是推动市场增长的关键因素之一。此外，以试剂为基础的方法的广泛采用也促进了市场的增长。与传统使用的技术相比，基于试剂的转染管理不那么复杂，而且更具成本效益。与此相一致的是，基于仪器的方法，如生物技术、微量注射和激光治疗，也在全球范围内获得了巨大的吸引力。细胞研究和治疗发现方面的各种技术进步是另一个主要的生长诱导因素。与此相一致，基因转移的研究主要是在体内条件下进行的，以开发新的治疗药物和各种其他应用。其他因素，包括政府和私人组织增加投资开发大规模转染设施，以及蛋白质疗法领域的广泛研究和开发(R&D)活动，预计将进一步推动市场。

Competitive Landscape:

竞争格局：

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

该报告还分析了市场的竞争格局，其中一些主要参与者是安捷伦技术公司、生物-RAD实验室公司、龙沙集团、Maxcell公司、Mirus生物有限责任公司、Polyplus Transporting公司、普罗米加公司、罗氏控股公司、西格玛-奥尔德里奇公司、赛默飞世尔等。本报告回答的关键问题：

  • How has the global transfection technologies market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the transfection technologies market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the transfection method?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transfection technologies market and who are the key players?
  • What is the degree of competition in the industry?
  • 到目前为止，全球转基因技术市场表现如何，未来几年将如何表现？
  • 主要的区域市场是什么？
  • 新冠肺炎对转基因技术市场有何影响？
  • 根据产品类型，市场的细分是什么？
  • 基于应用程序的市场细分是什么？
  • 以转染法为基础的市场瓦解是什么？
  • 基于技术的市场细分是什么？
  • 基于最终用户的市场细分是什么？
  • 产业价值链的各个阶段是什么？
  • 行业内的关键驱动因素和挑战是什么？
  • 全球转基因技术市场的结构是什么？谁是关键参与者？
  • 这个行业的竞争程度如何？

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Transfection Technologies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Reagent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instrument
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Application
7.1 Therapeutic Delivery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bio-Medical Research
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Protein Production
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by Transfection Method
8.1 Lipofection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Eletroporation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Nucleofection
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cotransfection
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Cationic Lipid Transfection
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 In-Vivo Transfection
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast

9 Market Breakup by Technology
9.1 Physical Transfection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Biochemical Based Transfection
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Viral-Vector Based Transfection
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by End-User
10.1 Research Centers and Academic Institutes
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals and Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast

11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bio-RAD Laboratories Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Lonza Group AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Maxcyte Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.3.3 Financials
15.3.5 Mirus Bio LLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Polyplus Transfection
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Promega Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Roche Holding AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Sigma-Aldrich Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Thermo Fisher Scientific Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

涵盖的主要主题： 1篇前言2范围和方法3执行摘要4简介4.1概述4.2主要行业趋势5全球转基因技术市场5.1市场概述5.2市场表现5.3.新冠肺炎的影响5.4市场预测6按产品类型细分的市场6.1试剂6.1.1市场趋势6.1.2市场预测6.2仪器6.2.1市场趋势6.2.2市场预测6.3人6.3.1市场趋势6.3.2市场预测7按应用程序细分市场7.1治疗性分娩7.1.1市场趋势7.1.2市场预测7.2生物医学研究7.2.1市场走势7.2.2市场预测7.3蛋白质生产7.3.1市场走势7.3.2市场预测7.4其他7.4.1市场趋势7.4.2市场预测8转染法拆分市场8.1脂质体8.1.1市场走势8.1.2市场预测8.2电穿孔8.2.1市场动向8.2.2市场预测8.3核分裂8.3.1市场趋势8.3.2市场预测8.4共转染8.4.1市场动向8.4.2市场预测8.5阳离子脂质转染8.5.1市场动向8.5.2市场预测8.6体内转染8.6.1市场动向8.6.2市场预测其他8.7人8.7.1市场走势8.7.2市场预测9按技术划分的市场细分9.1物理转染9.1.1市场趋势9.1.2市场预测9.2基于生化的转染9.2.1市场趋势9.2.2市场预测9.3基于病毒载体的转染9.3.1市场趋势9.3.2市场预测10按最终用户划分的市场细分10.1研究中心和学术机构10.1.1市场趋势10.1.2市场预测10.2家医院和诊所10.2.1市场趋势10.2.2市场预测10.3制药和生物技术公司10.3.1市场趋势10.3.2市场预测其他10.4人10.4.1市场趋势10.4.2市场预测11按地区划分的市场分类11.1北美11.1.1 美国11.1.1.1市场走势11.1.1.2市场预测11.1.2加拿大11.1.2.1市场走势11.1.2.2市场预测11.2 亚太地区11.2.1中国11.2.1.1市场走势11.2.1.2市场预测11.2.2 日本11.2.2.1市场走势11.2.2.2市场预测11.2.3印度11.2.3.1市场趋势11.2.3.2市场预测11.2.4 韩国11.2.4.1市场动向11.2.4.2市场预测11.2.5澳大利亚11.2.5.1市场动向11.2.5.2市场预测11.2.6 印度尼西亚11.2.6.1市场动向11.2.6.2市场预测11.2.7其他11.2.7.1市场走势11.2.7.2市场预测11.3欧洲11.3.1 德国11.3.1.1市场走势11.3.1.2市场预测11.3.2法国11.3.2.1市场走势11.3.2.2市场预测11.3.3 英国11.3.3.1市场走势11.3.3.2市场预测11.3.4意大利11.3.4.1市场动向11.3.4.2市场预测11.3.5 西班牙11.3.5.1市场动向11.3.5.2市场预测11.3.6俄罗斯11.3.6.1市场走势11.3.6.2市场预测11.3.7其他11.3.7.1市场走势11.3.7.2市场预测11.4 拉丁美洲11.4.1巴西11.4.1.1市场走势11.4.1.2市场预测11.4.2 墨西哥11.4.2.1市场走势11.4.2.2市场预测11.4.3其他11.4.3.1市场走势11.4.3.2市场预测11.5中东和非洲11.5.1市场动向11.5.2按国家/地区细分的市场11.5.3市场预测12 SWOT分析13价值链分析14架波特五力分析15竞争格局15.1市场结构15.2关键角色15.3主要玩家简介15.3.1安捷伦技术公司15.3.1.1公司概述15.3.1.2产品组合15.3.1.3财务15.3.1.4 SWOT分析15.3.2 Bio-RAD实验室公司15.3.2.1公司概述15.3.2.2产品组合15.3.2.3财务15.3.2.4 SWOT分析15.3.3龙沙集团股份公司15.3.3.1公司概述15.3.3.2产品组合15.3.3.3财务15.3.3.4 SWOT分析15.3.4 Maxcell Inc.15.3.4.1公司概述15.3.4.2产品组合15.3.3.3财务15.3.5 Mirus Bio LLC15.3.5.1公司概述15.3.5.2产品组合15.3.6 Polyplus转染15.3.6.1公司概述15.3.6.2产品组合15.3.7普罗米加公司15.3.7.1公司概述15.3.7.2产品组合15.3.8罗氏控股公司15.3.8.1公司概述15.3.8.2产品组合15.3.8.3财务15.3.9西格玛-奥尔德里奇公司15.3.9.1公司概述15.3.9.2产品组合15.3.10赛默飞世尔。15.3.10.1公司概述15.3.10.2产品组合15.3.10.3财务15.3.10.4 SWOT分析

For more information about this report visit https://www.researchandmarkets.com/r/haxkil

有关本报告的更多信息，请访问https://www.researchandmarkets.com/r/haxkil。

Media Contact:

媒体联系人：

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

研究和市场劳拉·伍德(Laura Wood)，高级经理[受电子邮件保护]对于E.S.T办公时间，请拨打电话：+1-917-300-0470美国/加拿大免费电话：+1-800-526-8630对于格林尼治标准时间办公时间，请致电+353-1-416-8900美国传真：646-607-1904传真(美国境外)：+353-1-481-1716

SOURCE Research and Markets

来源研究和市场

Related Links

相关链接

http://www.researchandmarkets.com

Http://www.researchandmarkets.com

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发